Showing results (491-500 of 537) with videos related to
Sort By:
Pageof 54
JCI Insight|June 18, 2021
COVID-19 and RA share an SPP1 myeloid pathway that drives PD-L1+ neutrophils and CD14+ monocytesLucy MacDonald, Stefano Alivernini, Barbara Tolusso, et al.Annals of the Rheumatic Diseases|May 18, 2010
IL-33 induces neutrophil migration in rheumatoid arthritis and is a target of anti-TNF therapyWaldiceu A Verri, Fabrício O Souto, Silvio M Vieira, et al.Immunity|June 18, 2015
Artery Tertiary Lymphoid Organs Control Aorta Immunity and Protect against Atherosclerosis via Vascular Smooth Muscle Cell Lymphotoxin β ReceptorsDesheng Hu, Sarajo K Mohanta, Changjun Yin, et al.Annals of the Rheumatic Diseases|December 20, 2023
Unmet need in rheumatology: reports from the Advances in Targeted Therapies meeting, 2023Kevin L Winthrop, Philip Mease, Andreas Kerschbaumer, et al.Annals of the Rheumatic Diseases|March 21, 2020
GO-DACT: a phase 3b randomised, double-blind, placebo-controlled trial of GOlimumab plus methotrexate (MTX) versus placebo plus MTX in improving DACTylitis in MTX-naive patients with psoriatic arthritisElsa Vieira-Sousa, Pedro Alves, Ana M Rodrigues, et al.Lancet (London, England)|February 16, 2024
Abatacept in individuals at high risk of rheumatoid arthritis (APIPPRA): a randomised, double-blind, multicentre, parallel, placebo-controlled, phase 2b clinical trialAndrew P Cope, Marianna Jasenecova, Joana C Vasconcelos, et al.Antimicrobial Agents and Chemotherapy|June 24, 2025
Clinical effectiveness, safety, and viral mutagenicity of oral favipiravir for COVID-19: results from a community-based, open-label, randomized Phase III trialMatthew Tate, Christopher J R Illingworth, Gordon MacGregor, et al.RMD Open|August 8, 2022
Gender equity in academic rheumatology, current status and potential for improvement: a cross-sectional study to inform an EULAR task forcePavel V Ovseiko, Laure Gossec, Laura Andreoli, et al.Cardiovascular Research|May 1, 2020
COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment optionsTomasz J Guzik, Saidi A Mohiddin, Anthony Dimarco, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 13, 2018
ILDR2 Is a Novel B7-like Protein That Negatively Regulates T Cell ResponsesIris Hecht, Amir Toporik, Joseph R Podojil, et al.Pageof 54